Policy perspectives on the sustainable introduction of pneumococcal conjugate vaccines in middle-income countries
View ORCID ProfileRose Weeks, View ORCID ProfileBaldeep K. Dhaliwal, View ORCID ProfileJasmine Huber, View ORCID ProfileSarah Nabia, View ORCID ProfileAla’a F. Al-Shaikh, Kulkanya Chokephaibulkit, View ORCID ProfileLaKKumar Fernando, View ORCID ProfileEhssan Baghagho, View ORCID ProfileAnita Shet
doi: https://doi.org/10.1101/2024.06.07.24308483
Rose Weeks
1International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21231, USA
Baldeep K. Dhaliwal
1International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21231, USA
Jasmine Huber
1International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21231, USA
Sarah Nabia
1International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21231, USA
Ala’a F. Al-Shaikh
2World Health Organization, Amman, 811547 Jordan
Kulkanya Chokephaibulkit
3Pediatric Infectious Division Unit, Mahidol University Bangkok, 10700, Thailand
LaKKumar Fernando
4Nawaloka Hospital, Colombo 00200, Sri Lanka
Ehssan Baghagho
5General Organization for Teaching Hospitals and Institutes (GOTHI), Cairo 4260010, Egypt
Anita Shet
1International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 21231, USA
Article usage
Posted June 10, 2024.
Policy perspectives on the sustainable introduction of pneumococcal conjugate vaccines in middle-income countries
Rose Weeks, Baldeep K. Dhaliwal, Jasmine Huber, Sarah Nabia, Ala’a F. Al-Shaikh, Kulkanya Chokephaibulkit, LaKKumar Fernando, Ehssan Baghagho, Anita Shet
medRxiv 2024.06.07.24308483; doi: https://doi.org/10.1101/2024.06.07.24308483
Policy perspectives on the sustainable introduction of pneumococcal conjugate vaccines in middle-income countries
Rose Weeks, Baldeep K. Dhaliwal, Jasmine Huber, Sarah Nabia, Ala’a F. Al-Shaikh, Kulkanya Chokephaibulkit, LaKKumar Fernando, Ehssan Baghagho, Anita Shet
medRxiv 2024.06.07.24308483; doi: https://doi.org/10.1101/2024.06.07.24308483
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (690)
- Anesthesia (185)
- Cardiovascular Medicine (2781)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12432)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4298)
- Geriatric Medicine (397)
- Health Economics (705)
- Health Informatics (2776)
- Health Policy (1029)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (406)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4073)
- Nursing (218)
- Nutrition (603)
- Oncology (2155)
- Ophthalmology (609)
- Orthopedics (252)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (79)
- Pathology (480)
- Pediatrics (1152)
- Primary Care Research (473)
- Public and Global Health (6679)
- Radiology and Imaging (1457)
- Respiratory Medicine (889)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)